Literature DB >> 24213753

Monoclonal T-cell receptor drugs pique pharma's interest.

Cormac Sheridan.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24213753     DOI： 10.1038/nbt1113-950b

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  6 in total

1.  Amgen swallows Micromet to BiTE into ALL market.

Authors:  Cormac Sheridan
Journal:  Nat Biotechnol       Date:  2012-04-10       Impact factor: 54.908

2.  Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2.

Authors:  Richard A Morgan; James C Yang; Mio Kitano; Mark E Dudley; Carolyn M Laurencot; Steven A Rosenberg
Journal:  Mol Ther       Date:  2010-02-23       Impact factor: 11.454

3.  Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy.

Authors:  Richard A Morgan; Nachimuthu Chinnasamy; Daniel Abate-Daga; Alena Gros; Paul F Robbins; Zhili Zheng; Mark E Dudley; Steven A Feldman; James C Yang; Richard M Sherry; Giao Q Phan; Marybeth S Hughes; Udai S Kammula; Akemi D Miller; Crystal J Hessman; Ashley A Stewart; Nicholas P Restifo; Martha M Quezado; Meghna Alimchandani; Avi Z Rosenberg; Avindra Nath; Tongguang Wang; Bibiana Bielekova; Simone C Wuest; Nirmala Akula; Francis J McMahon; Susanne Wilde; Barbara Mosetter; Dolores J Schendel; Carolyn M Laurencot; Steven A Rosenberg
Journal:  J Immunother       Date:  2013-02       Impact factor: 4.456

4.  Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells.

Authors:  Brian J Cameron; Andrew B Gerry; Joseph Dukes; Jane V Harper; Vivekanandan Kannan; Frayne C Bianchi; Francis Grand; Joanna E Brewer; Minnal Gupta; Gabriela Plesa; Giovanna Bossi; Annelise Vuidepot; Alex S Powlesland; Alison Legg; Katherine J Adams; Alan D Bennett; Nicholas J Pumphrey; Daniel D Williams; Gwendolyn Binder-Scholl; Irina Kulikovskaya; Bruce L Levine; James L Riley; Angel Varela-Rohena; Edward A Stadtmauer; Aaron P Rapoport; Gerald P Linette; Carl H June; Namir J Hassan; Michael Kalos; Bent K Jakobsen
Journal:  Sci Transl Med       Date:  2013-08-07       Impact factor: 17.956

5.  Monoclonal TCR-redirected tumor cell killing.

Authors:  Nathaniel Liddy; Giovanna Bossi; Katherine J Adams; Anna Lissina; Tara M Mahon; Namir J Hassan; Jessie Gavarret; Frayne C Bianchi; Nicholas J Pumphrey; Kristin Ladell; Emma Gostick; Andrew K Sewell; Nikolai M Lissin; Naomi E Harwood; Peter E Molloy; Yi Li; Brian J Cameron; Malkit Sami; Emma E Baston; Penio T Todorov; Samantha J Paston; Rebecca E Dennis; Jane V Harper; Steve M Dunn; Rebecca Ashfield; Andy Johnson; Yvonne McGrath; Gabriela Plesa; Carl H June; Michael Kalos; David A Price; Annelise Vuidepot; Daniel D Williams; Deborah H Sutton; Bent K Jakobsen
Journal:  Nat Med       Date:  2012-06       Impact factor: 53.440

6.  A single autoimmune T cell receptor recognizes more than a million different peptides.

Authors:  Linda Wooldridge; Julia Ekeruche-Makinde; Hugo A van den Berg; Anna Skowera; John J Miles; Mai Ping Tan; Garry Dolton; Mathew Clement; Sian Llewellyn-Lacey; David A Price; Mark Peakman; Andrew K Sewell
Journal:  J Biol Chem       Date:  2011-11-18       Impact factor: 5.157
  6 in total
  2 in total

Review 1.  The T cell antigen receptor: the Swiss army knife of the immune system.

Authors:  M Attaf; M Legut; D K Cole; A K Sewell
Journal:  Clin Exp Immunol       Date:  2015-05-14       Impact factor: 4.330

Review 2.  The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapy.

Authors:  Mateusz Legut; David K Cole; Andrew K Sewell
Journal:  Cell Mol Immunol       Date:  2015-04-13       Impact factor: 11.530
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.